BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2019 10:17:12 AM | Browse: 1309 | Download: 1855
 |
Received |
|
2019-03-11 09:18 |
|
Peer-Review Started |
|
2019-03-12 01:17 |
|
To Make the First Decision |
|
2019-05-09 00:22 |
|
Return for Revision |
|
2019-05-09 02:00 |
|
Revised |
|
2019-05-13 07:26 |
|
Second Decision |
|
2019-05-13 11:15 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-05-14 01:32 |
|
Articles in Press |
|
2019-05-14 01:32 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-05-14 09:50 |
|
Publish the Manuscript Online |
|
2019-05-15 10:17 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Management of diabetic dyslipidemia: An update
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ishwarlal Jialal and Gurdeep Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ishwarlal Jialal, MD, PhD, Professor, California North-state University College of Medicine, VA Medical Center, Mather, 9700 West Taron Drive, Elk Grove, CA 95757, United States. ishwarlal.jialal@cnsu.edu |
| Key Words |
Diabetes; Dyslipidemia; Statins; Atherosclerosis; Ezetimibe |
| Core Tip |
Atherosclerotic cardiovascular disease (ASCVD) is the major cause of mortality in diabetes. Low-density lipoprotein (LDL)-cholesterol lowering with statins reduce ASCVD and is the mainstay of therapy. Also, both ezetimibe and PCSK9 inhibitors are useful strategies when statins cannot be tolerated or the LDL-cholesterol goal is not achieved. |
| Publish Date |
2019-05-15 10:17 |
| Citation |
Jialal I, Singh G. Management of diabetic dyslipidemia: An update. World J Diabetes 2019; 10(5): 280-290 |
| URL |
https://www.wjgnet.com/1948-9358/full/v10/i5/280.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v10.i5.280 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
